News |

Study provides confidence in timeliness and sensitivity of AusVaxSafety

A new simulation study on Australia’s leading active vaccine safety surveillance system, AusVaxSafety, has been released that shows that the system is robust and would have detected a vaccine safety signal had it been operating in 2010 when there was an unprecedented number of febrile seizures in young children associated with one specific influenza vaccine brand, Fluvax (CSL Biotherapies). Fluvax was subsequently prohibited for use in children.

Read more on AusVaxSafety website. 



News & events

News |

More vaccines at one visit doesn’t mean more side effects, Australian study finds
News |

A generation protected: how HPV vaccination could change the future for girls in Papua New Guinea
News |

New study finds changes to herpes zoster vaccination in Australia have contributed to a decline in cases

News |

NCIRS moves into its next phase of leadership as Director takes up Australian CDC role
News |

Multiple generations of Australians at risk of measles − how protected is your generation?
News |

20 years of HPV vaccination: celebrating progress and recognising ongoing challenges

News |

Country is our teacher: literacy, comprehension and the knowledge that protects us

News |

1.7 million Australians unprotected against measles, raising the risk of local outbreaks
News |

Honouring Indigenous knowledge: immunisation and the UN International Day of the World's Indigenous Peoples 2026
News |

Towards eliminating cervical cancer – tracking HPV vaccination progress in LMICs
All news & events